Prospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2048-2060
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048
Figure 2
Figure 2 Kaplan-Meier survival analysis of disease-free survival and overall survival rates in relation to HER2 status. A: HER2 overexpression in rectal cancers is correlated with a shorter disease-free survival, P = 0.048; B: HER2 overexpression in rectal cancers is correlated with a shorter overall survival, P = 0.0077. DFS: Disease-free survival; OS: Overall survival.